STK11 and non-small cell lung carcinoma: Somatic mutation(s) of LKB1, a tumor suppressor to upregulate AMPK-related catabolic and anabolic pathways, is viewed as an important cause of cancer development and poor prognosis in patients with NSCLC, hepatocarcinoma, and colorectal cancer [30, 37, 38].